ARIA
Library/muscular/GH Fragment 1-34

GH Fragment 1-34

Not FDA Approved⛔ WADA Banned
muscularEmergingGH fragment

First 34 amino acids of human growth hormone — retains the lipolytic and anabolic properties of full-length GH without the diabetogenic effects. Discovered by C.H. Li in the 1970s. Does not significantly raise IGF-1 levels, making it safer for long-term use.

Confidence
65%
Half-Life ~30 minutes
Cost ~$400/mo
Quick Reference
Routesubcutaneous
MechanismRetains the lipolytic and anabolic domain of GH (helix 1 region). Binds GH recep...
Reviewed2026-06-08

Mechanism of Action

Retains the lipolytic and anabolic domain of GH (helix 1 region). Binds GH receptor → activates lipolysis and protein synthesis pathways without significant IGF-1 elevation. No diabetogenic effect.

Dosing Protocol

100-300mcg subQ 1-2x daily. Often stacked with GHRPs for enhanced GH pulse.

Adverse Effects

Mild hungerInjection site reactionsWater retention (rare)Carpal tunnel (with prolonged high doses)

Contraindications

  • Active malignancy
  • Pregnancy
  • Diabetes (use caution)

Storage

Refrigerate 2-8°C. Reconstitute with bacteriostatic water.